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Abstract 
Myocardial infarction animal studies are used to study disease mechanisms and new treatment options. Typically, 
myocardial infarction (MI) is induced by permanent occlusion of the left anterior descending artery. Since in MI 
patients coronary blood flow is often restored new experimental models better reflecting clinical practice are needed. 
Here, permanent ischemia MI (PI group) was compared with transient ischemia (45 min) (IR group) in immunode‑
ficient NOD/Scid mice. Cardiac function, infarct size, wall thickness and total collagen deposition were significantly 
reduced only in PI mice. Cardiac inflammatory cells and serum cytokine levels were less dynamic in IR animals 
compared to PI. So although IR better reflects clinical practice, it is secondary to PI for investigating cell therapy, since 
it induces too little damage to provide a measurable therapeutic window. MI did result in significant changes in the 
inflammatory state, indicating this immunodeficient mouse strain is valuable to study human cell therapy.
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Background
As cardiovascular diseases, including myocardial infarc-
tion (MI), remain one of the leading causes of death 
globally (Roger et al. 2012), the search for new therapies 
continues. Cell therapy has emerged over the past years 
as a potential treatment modality for MI patients in addi-
tion to conventional treatment (Zimmet et  al. 2012). 
Before the various candidate cell types are to be applied 
in clinical trials, they have to be investigated in experi-
mental disease animal models (Johnston et al. 2009; Wil-
liams and Hare 2011; Katare et al. 2011; Yoon et al. 2010; 
Gu et al. 2012). To mimic future clinical use of these cells 
as much as possible, typically human cells are studied in 
animal models. To avoid rejection of these infused cells 
by the immune system of the host and to avoid the use 
of pharmacological immune suppression, immune-
deficient animals such as the non-obese diabetic/severe 
combined immunodeficient (NOD/Scid) mice strain are 
used. The SCID mutation results in an impaired T and B 
cell lymphocyte development which allows transplanta-
tion of different cell-types originating e.g. from periph-
eral blood, bone-marrow or organs (Simpson et al. 1991). 
MI in mouse models typically is induced through perma-
nent ligation of the left anterior descending artery (LAD). 
However, in current clinical practice rapid restoration of 
coronary blood flow is the cornerstone of MI treatment, 
rendering the permanent coronary artery ligation mouse 
model less representative of the clinical situation.
Tissue inflammation is an important element in cardiac 
remodelling after MI. Coronary artery occlusion induces 
an inflammatory cascade which can be divided in three 
partially overlapping phases of inflammation, prolifera-
tion and maturation (Frangogiannis 2006). Reperfusion 
of infarcted cardiac tissue leads to an increased and 
accelerated inflammatory response possibly deteriorating 
cardiac remodelling (Entman and Smith 1994).
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In the present study MI induced by permanent coro-
nary occlusion of the LAD (PI group) was compared 
with ischemia–reperfusion MI by transient ligation of 
the LAD (IR group). MI was induced in the immunode-
ficient NOD/Scid mice, a strain necessary to study the 
effects of human cell therapy. In both MI models cardiac 
function was assessed by magnetic resonance imaging 
(MRI) and pressure–volume (PV) loop measurements. 
Furthermore infarct size was assessed by MRI and histol-
ogy and parameters of local and systemic inflammatory 
response were investigated to determine the relevance of 
this immunodeficient mice strain in MI research.
Methods
Animals
Experiments were performed in 8- to 10-weeks-old male 
NOD/Scid mice (Charles River Laboratories, Maastricht, 
The Netherlands). Experiments were approved by the 
Committee on Animal Welfare of the Leiden Univer-
sity Medical Center and conformed to the Guide for the 
Care and Use of Laboratory as stated by the U.S. National 
Institutes of Health. Animals were housed in filter top 
cages and were given standard diet and water with antibi-
otics and antimycotics ad libitum.
MI model
MI was induced in NOD/Scid mice by permanently (PI 
group) or transiently (45  min) (IR group) ligating the 
LAD. Sham-operated animals were used to determine 
baseline characteristics (Sham group). Mice received 
100  µL NaCl, containing 2  µg buprenorphine, sub-
cutaneously before surgery and again 12  h after sur-
gery. The permanent ligation MI model was induced as 
described earlier (den Haan et al. 2012). Briefly, animals 
were anesthetized with 5% isoflurane for induction and 
kept anesthetized with 1.5–2% isoflurane in oxygen for 
the remainder of the surgical procedure, intubated and 
ventilated using a rodent ventilator (model 845, Har-
vard Apparatus, Holliston, MA, USA) with 160 breaths 
per min and a stroke volume of 220  μL. A left thora-
cotomy was performed and the LAD was ligated using 
a 7-0-prolene suture (Johnson and Johnson, New Brun-
swick, NJ, USA). For the permanent ligation experiment 
(PI group), the location of the LAD ligation was 1  mm 
caudally from the tip of the left auricle. For the tran-
sient ligation and subsequent reperfusion experiment 
(IR group), the LAD was transiently ligated for 45  min 
directly underneath the tip of the left auricle to induce 
maximum damage, followed by reperfusion. To allow 
reperfusion of the LAD after 45  min, the ligation was 
fixed on a tube placed directly on the LAD. Ischemia was 
confirmed by myocardial blanching. The chest was left 
open during the entire ischemic period. Based on pilot 
data transient ligation was performed for 45  min, since 
an ischemia duration ≥50  min resulted in unacceptable 
high mortality rates (100%, either during the ischemic 
period or afterwards within the first week of the pro-
cedure). Five  min after LAD ligation in the PI group or 
5 min after reperfusion in the IR group, animals received 
15  μL phosphate-buffered saline intramyocardially to 
mimic intramyocardial cell therapy. After 35  min of 
LAD ligation mice received an intraperitoneal injection 
of lidocaine (6  mg/kg) to prevent cardiac arrhythmias 
(Tarnavski et al. 2004). Afterwards, the chest was closed 
and animals were allowed to recover. Sham animals 
were operated in parallel, but without LAD ligation and 
intramyocardial injection, and were used to determine 
baseline characteristics (Sham group).
The mortality rate of the IR group was 33.3% at the 
end of the experiment, with 25% mortality during the 
ischemic period or afterwards at the same day of the pro-
cedure and 75% mortality during the follow up period of 
the experiment or during MRI measurements.
The mortality rate of the PI group was 41.2% at the end 
of the experiment, with 14.3% mortality during the pro-
cedure or afterwards at the same day of the procedure 
and 85.7% mortality during the follow up period of the 
experiment or during MRI measurements.
The mortality rate of the Sham group was 25% at the 
end of the experiment with 100% mortality during 
the follow up period of the experiment or during MRI 
measurements.
Cardiac MRI
Cardiac parameters were assessed 2 and 14  days post-
MI using a 7-Tesla MRI (BrukerBiospin, Ettlingen, Ger-
many). Mice were anesthetized with 5% isoflurane for 
induction and kept anesthetized with 1.5–2% isoflu-
rane in oxygen for the remainder of the procedure and 
placed on a respiration detection cushion connected to 
a gating module to monitor respiratory rate (SA Instru-
ments, Inc., Stony Brook, NY, USA). Image reconstruc-
tion was performed using BrukerParaVision5.1 software 
(BrukerBiospin, Ettlingen, Germany). To evaluate cardiac 
function, a high-resolution 2D FLASH cine sequence 
was used to acquire a set of 9 contiguous 1 mm slices in 
short-axis orientation covering the entire heart. Imaging 
parameters were: echo time of 1.49  ms, repetition time 
of 5.16  ms, field of view (26  mm)2 and a matrix size of 
144 × 192. To determine infarct size, contrast enhanced 
MRI imaging was performed after injection of a 150 µL 
bolus (0.5  mmol/mL) of gadolinium-DPTA (Gd-DPTA, 
Dotarem, Guerbet, The Netherlands) via the tail vein. A 
gradient echo sequence (FLASH) was used to acquire a 
set of 14 contiguous 0.7 mm contract-enhanced slices in 
short-axis orientation covering the entire heart. Imaging 
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parameters were: echo time of 1.9  ms, repetition time 
of 84.16 ms, field of view (33 mm)2 and a matrix size of 
192 ×  256. All MR data were analysed with the MASS 
for Mice software package (MEDIS, Leiden, The Nether-
lands). Endocardial and epicardial borders were manu-
ally delineated and a reference point was positioned by 
an investigator blinded to the experimental status of the 
data (PI group n = 5, IR group n = 5, Sham group n = 5, 
overall 15 mice for statistical analysis).
Left ventricular function by PV loops
At day 15 after MI, mice were anesthetized again with 
5% isoflurane for induction and kept anesthetized with 
1–1.5% isoflurane in oxygen for the remainder of the 
procedure. Via the right carotid artery, a 1.2F pressure-
conductance catheter (standard; ScisenseInc, London, 
Canada) was introduced and positioned in the left ven-
tricle (LV). The conductance catheter was connected to a 
PV control unit FV 896B (ScisenseInc, London, Canada) 
for online display and recording of LV pressure and vol-
ume signals. Parallel conductance and LV pressure–vol-
ume signals were measured as described previously (den 
Haan et al. 2012; Steendijk and Baan 2000). All data were 
acquired using Powerlab 8/30 Model ML870 (ADInstru-
ments, Spechbach, Germany) and LabChart  7 software 
(ADInstruments, Spechbach, Germany). Data were ana-
lyzed with custom-made software by an investigator 
blinded to the experimental status of the data (PI group 
n = 5, IR group n = 5, Sham group n = 5, overall 15 mice 
for statistical analysis).
Histological infarct size
After PV loops hearts were dissected, fixed and cut as 
described earlier (PI group n = 4, IR group n = 4, Sham 
group n  =  4, overall 12 mice for statistical analysis) 
(den Haan et al. 2012). The extent of total collagen dep-
osition after MI was evaluated by staining with picro-
sirius red (0.5 g Sirius red in 500 mL saturated aqueous 
solution of picric acid) for 1  h. Total collagen deposi-
tion was determined by the area stained tissue within 
the LV as a percentage of the whole LV. This analysis 
was performed on photomicrographs taken at a twofold 
magnification of 15–20 sections covering the entire 
heart from apex to base. The area of Sirius red stain-
ing was measured by an observer blinded to the experi-
mental status of the samples, using the ImageJ software 
package (National Institutes of Health, Bethesda, MA, 
USA).
The effect of MI on LV wall thickness was assessed on 
the same sections. This analysis was performed on three 
equidistant sections between the apex and ligature (at 
the midpoint between the LAD ligature and the apex, 
between the midpoint and the LAD ligature and between 
the midpoint and apex). Wall thickness was measured at 
two separate border zone areas, at the midpoint of the 
infarct region and averaged for all three measurements. 
Measurements were performed perpendicular to the 
infarcted wall.
Cardiac inflammation response
In parallel to the above described experiment, MI was 
induced by PI or IR in mice that were sacrificed on 
days 1, 3, and 7 after MI (n  =  3 mice per time point, 
overall PI group n =  9, overall IR group n =  9). Non-
operated animals were used as controls to determine 
base line characteristics at 1 time point (Control group, 
n  =  3, overall 21 mice for statistical analysis). Hearts 
were harvested in total, minced with fine scissors, and 
placed into a solution of 2% collagenase IA (Sigma-
Aldrich, Saint Louis, MO, USA) in PBS and shaken at 
37°C for 1  h. The cell suspension was then triturated 
through a nylon mesh and centrifuged in PBS at 300g 
for 10 min at 4°C. Red blood cells in the cell pellet were 
lysed with lysis buffer, and the cells were washed in PBS 
and subsequently resuspended in medium containing 
IMDM (Lonza, Verviers, Belgium) supplemented with 
2.5% fetal calf serum (FCS; Greiner Bio-one, Monroe, 
NC, USA) and Penicillin/Streptomycin (P/S; Invitro-
gen Corp., Paisley, UK). Total cardiac cell numbers 
were determined with a Sysmex cell counter (Sysmex 
America, Inc. Mundelein, Illinois, USA). The resulting 
single-cell suspensions were stained for flow cytometry 
with primary antibodies for 30  min at 4°C in darkness 
and the cells were washed with PBS/1% human Albu-
min (Sanquin, Leiden, The Netherlands) before analysis 
using a FACSCanto II (BD Biosciences, San Diego, CA, 
USA). The following antibodies were used: anti-CD90-
APC, 53–2.1, -B220-APC, RA3-6B2, -CD49b-APC, 
DX5, -NK1.1-APC, PK136, -Ly-6G-APC, 1A8, CD11b-
eFluor 450, M1/70, -F4/80-FITC, -CD11c-FITC, HL3, 
-I-Ab -FITC, AF6-120.1, -Ly-6C-PE, AL-21, -CD11c-PE, 
HL3 (All above antibodies are from BD Biosciences) 
and C1:A3-1 (ABD Serotec, Kidlington, UK). Mono-
cytes were identified as CD11b high (CD90/B220/
CD49b/NK1.1/Ly-6G) low. They were further divided 
into Ly-6C high/low (F4/80/I-Ab/CD11c) low as previ-
ously described (Nahrendorf et  al. 2007; Swirski et  al. 
2009). Macrophages were identified as CD11b high, 
F4/80 high. Dendritic cells were identified as CD11b, 
I-Ab and CD11c high. Neutrophils were identified as 
CD11b, Ly-6G high. Monocyte and macrophage/den-
dritic cell numbers were calculated as the total cells 
multiplied by the percentage of cells within the mono-
cyte/macrophage gate. The analysis of the acquired data 
was done with FlowJo software version 7.6.1 (Tree Star 
Inc. Ashland, OR, USA).
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Cytokine measurements
Cytokine measurements were performed on peripheral 
blood from the same mice that were used to determine 
the cardiac inflammation response. Mice were sacrificed 
on days 1, 3, and 7 after MI (n = 3 mice per time point, 
overall PI group n  =  9, overall IR group n  =  9). Non-
operated animals were used as controls to determine 
base line characteristics (Control group, n = 3, overall 21 
mice for statistical analysis). Peripheral blood was drawn 
via cardiac puncture and collected in eppendorf tubes to 
let the blood coagulate >2 h at room temperature. Sub-
sequently, the samples were centrifuged to separate the 
blood clot from the serum and the serum was stored at 
−80°C until cytokine determination. Cytokine concentra-
tions were measured using the Bio-PlexMouse Cytokine 
23-plex Panel assay (Bio-Rad laboratories, Inc, Hercules, 
CA, USA).
Statistical analysis
Numerical values were expressed as mean  ±  standard 
deviation (SD). Comparison of MRI parameters between 
the PI, IR and Sham group was performed using two-
way repeated-measures analysis of variance (ANOVA), 
with Bonferroni correction. Comparison of the remain-
ing parameters between the PI, IR and Sham or Control 
group was performed using one-way ANOVA, with Bon-
ferroni correction.
Results
MRI: infarct size and cardiac function
Both 2 and 14 days after MI, the infarct size in animals 
that were subjected to PI (n = 5) was significantly larger 
than in the IR model (n = 5) (Figure 1a). This difference 
in damage between both MI groups was reflected by the 
cardiac function in the two models. Two days after MI, 
ejection fraction decreased significantly in the PI group, 
with a further deterioration of function 14 days after MI 
(Figure 1b). Both end-diastolic and end-systolic volumes 
tended to increase in the PI group 2  days post-MI and 
reached significance at day 14 after MI, when compared 
to the IR and Sham group (Figure 1c, d). Likewise, stroke 
volume, cardiac output, wall thickening and wall motion 
deteriorated significantly in PI animals at day 14  days 
after MI (Additional file 1: Table S1). In contrast, cardiac 
function parameters in IR animals did not significantly 
differ from those in Sham animals.
In accordance with the MRI data, PV loop measure-
ments 15  days after MI showed a significant deteriora-
tion in cardiac function in the PI group, but not in the IR 






















































































Figure 1 Assessment of left ventricular function and volumes with MRI. MRI analysis of delayed contrast‑enhanced images showed a significant 
difference in infarct size (a) between the PI and IR group, both at t = 2 and t = 14. Assessment of left ventricular function of the PI, IR and Sham 
group at t = 2 and t = 14: ejection fraction (b), end‑diastolic volume (c) and end‑systolic volume (d). N = 5 per group. Data are expressed as 
mean ± SD. *p < 0.05 versus IR, #p < 0.05 versus Sham.
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Histology: infarct size
Consistent with the observed difference in infarct size 
observed by MRI, animals that were subjected to PI 
showed a significant increase in total collagen deposi-
tion (19.0%) 15 days after MI, as opposed to IR (2.7%) and 
Sham (0.3%) (n=4 in all groups) (Figure 2a–d). In addition, 
quantification of wall thickness showed a significant thin-
ning of the LV wall after MI in the PI group (0.43 mm), but 
not in the IR group (0.83 mm), where wall thickness was 












































Figure 2 Histological quantification of total collagen deposition and wall thickness. Photos of representative sections of the hearts of PI (a), IR (b) 
and Sham (c) mice 15 days after MI showing total collagen deposition (red) by Sirius red staining. Quantification of Sirius red staining (d). Quantifica‑
tion of LV wall thickness (e). N = 4 per group. Data are expressed as mean ± SD. *p < 0.05 versus IR, #p < 0.05 versus Sham.
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Cardiac inflammation response
The effect of MI on the local influx of inflammatory cells 
in both the PI and IR group was assessed by flow cytome-
try and compared to non-operated control animals. Flow 
cytometric analyses on single cell heart digests revealed 
significantly increased neutrophil frequencies in the PI 
group on the first day after MI, which declined thereaf-
ter (Figure 3a). Cardiac inflammatory monocyte popula-
tions however, were significantly reduced in both the PI 
and IR group at both day 1 and 3 after MI. The frequency 
of non-inflammatory monocytes was reduced as well in 
both groups, but the kinetic for this cell population was 
slower as it was only significant 3 days after MI.
Cardiac macrophages and dendritic cell frequencies in 
either of the MI groups, however, did not significantly 
deviate from the control group, suggesting these cell 
types are less relevant in the cardiac inflammatory pro-
cess within the first week after MI (Figure 3b).
Cytokine measurements
In the PI group, the average serum levels of the known 
relevant pro-inflammatory cytokines tumor necrosis fac-
tor α (TNF-α), IL-1β, and IL-6, and the anti-inflamma-
tory cytokine IL-10 were found to be increased at day 
1 post MI, and these serum levels gradually decreased 
thereafter. Statistically, however these differences did 
not meet significance (Figure  4a). In the IR group 
injury induced lower levels of these cytokines but these 
seemed to be sustained for a longer period. In addition, 
the other cytokines that were measured via ELISA were 
IL-5, MCP-1, MIP-1β, G-CSF, GM-CSF, IL-12(p40), KC, 
RANTES, IL-17, and IL-2, of which MCP-1, MIP-1β, 
G-CSF appeared to be more dynamic in the PI group 
compared to the IR group, although this was not signifi-
cantly different (Figure 4b).
Discussion
Key findings of the current study are that MI by IR results 
in (1) a non-significant deterioration of cardiac func-
tion and remodeling compared with Sham animals, (2) 
a reduced population of cardiac inflammatory cells, (3) 
limited dynamics in serum cytokine levels and (4) non-
significant total collagen deposition and wall thinning.
So, despite the resemblance of the IR model to the cur-
rent clinical practice, this study demonstrates its role for 
cell therapy optimization is limited, since IR fails to inflict 
sufficient myocardial damage to create the experimental 
window necessary to monitor significant improvement.
Earlier research by Vandervelde et  al. already showed 
less pronounced remodelling in mouse hearts subjected 
to transient ligation, when compared to permanent liga-
tion (Vandervelde et  al. 2006). A more recent study, 
which compared transient ligation to permanent liga-
tion by cryoinfarction showed the same results (Duerr 
et al. 2011). However, it should be noted that permanent 
ligation by cryoinfarction is mechanistically different 
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Figure 3 Flow cytometric analysis of inflammatory cells. MI in the PI model induces marked neutrophil recruitment and an egress of monocytes 
(a) within 7 days after injury measured via flow cytometry on hole heart digests. Cardiac macrophages and dendritic cell percentages are unaltered 
after myocardial injury (b). N = 3 per group. Data are expressed as mean ± SD. #p < 0.05 versus Control.
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to permanent ligation used in this study. Permanent 
ischemia by cryoinfarction resulted in a prolonged 
remodelling period and excess remodelling, when com-
pared to transient ligation (Duerr et al. 2011). Although 
cardiac function was not investigated in both studies, the 
possible difficulties in testing a therapeutic intervention 
due to less damage were discussed.
Our findings on infarct size differences between the PI 
and IR group were consistent with other studies, which 
also showed a significantly larger infarct size after per-
manent ligation, measured by both contrast-enhanced 
MRI (Luo et al. 2012) and histological staining (Luo et al. 
2012; Michael et  al. 1999). Furthermore, we found that 
only PI resulted in significant thinning of the LV wall, 
which was also in line with earlier research (Vandervelde 
et al. 2006). Solely based on the small decline in cardiac 
function and the limited cardiac remodelling after MI, IR 
induces little damage, while ischemia durations ≥50 min 
resulted in unacceptable high mortality rates in a pilot 
study. The mostly observed cause of death in this pilot 
study was death by cardiac arrhythmia, which was moni-
tored by 3-lead EKG (data not shown). Overall, IR leaves 
a small window for therapeutic intervention.
Besides the effect of PI and IR on cardiac function 
and remodeling, we also investigated and compared 
the inflammatory response. After occlusion of a coro-
nary artery several chemokine and cytokine cascades are 
activated during the first phase of cardiac inflammation, 
the inflammatory phase. Subsequently dead cells and 
matrix debris are removed from the wound by neutrophils 
and macrophages. This is followed by the deposition of 
extracellular matrix proteins and formation of an exten-
sive microvascular network during the proliferation phase 
of cardiac inflammation. Afterwards, maturation of the 
scar follows and a collagen-based scar is formed (Frango-
giannis 2006, 2008) during the final maturation phase.
After MI inflammatory monocytes present in the car-
diac tissue give rise to macrophages, while the role of 
non-inflammatory monocytes is not yet clear (Nah-
rendorf and Swirski 2013). In the current study the fre-
quency of the inflammatory and non-inflammatory 
monocytes was reduced in both models within the first 
week after MI, suggesting the inflammatory monocytes 
are indeed differentiating into macrophages. However, no 
increased number of macrophages in the cardiac tissue in 
either the PI or the IR model was observed. In addition, 
a significant influx of neutrophils in the PI group was 
detected. This is in contrast to earlier studies by Luo et al. 
and Vandervelde et  al. where increased influx of mac-
rophages and neutrophils was observed after reperfu-
sion compared to permanent ligation (Vandervelde et al. 
2006; Luo et al. 2012). Also no increase in dendritic cell 
numbers was detected here, as opposed to observations 
in other experimental settings (Anzai et al. 2012).
IL-5























































































































































































































Figure 4 Cytokine levels in blood serum. Blood serum analyses appear to show a more dynamic induction in the PI group within 1 day after MI of 
TNFα, IL1β, IL‑10, and IL‑6, which are important cytokines after MI (a) and a range of various other cytokines (b). N = 3 per group. Data are expressed 
as mean ± SD. #p < 0.05 versus Control.
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In the current study, the upregulation of inflammatory 
cytokines after MI, initiating the inflammatory process, 
was modest compared to earlier research (Frangogiannis 
2008; Moro et  al. 2007). However, a direct comparison 
in cytokine levels between the PI and IR group suggests 
that the extent of injury dictates the systemic inflamma-
tory response, since the limited cardiac damage in the IR 
model related to the less dynamic changes in the cytokine 
profile. The observed differences in inflammatory 
response between this study and earlier research may be 
explained by the difference in immune systems between 
the mice strains used. Since the primary goal of the cur-
rent study was to investigate human cell therapy in a more 
clinically relevant MI model immunodeficient mice were 
used, which have an impaired repertoire of immune cells, 
capable of performing innate immunity only. Despite of 
this impaired immune response in NOD/Scid mice, this 
study shows that inducing MI still results in significant 
changes in the immune state of these animals, indicating 
this mouse strain can still be valuable to study human cell 
therapy.
Conclusions
MI by transient ligation results in a limited loss of cardiac 
function, minimal cardiac remodeling and a less dynamic 
inflammatory response, compared to the most widely 
used model of permanent ligation. So, although a model 
of transient ligation may better mimic the clinical situa-
tion, the limited myocardial damage renders it less suit-
able to study novel therapies including stem cell therapy. 
Furthermore even in the immunodeficient mice strain 
used, MI does significantly alter the inflammatory state.
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